Cited by 256Cholinesterase and Neurodegenerative DiseasesAlzheimer's disease research and treatmentsEnzyme function and inhibition

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Targeting Beta-Amyloid Pathogenesis Through Acetylcholinesterase Inhibitors

Castro, Ana, Martinez, Ana·2006·Current Pharmaceutical Design

DOI 10.2174/138161206778792985

Open this paper in CoChat — free account

Abstract

Although the hallmarks of neurodegeneration in Alzheimer's brains are well known, one of the current difficulties is related to the lack of solid evidence about the ultimate factors that give rise to the pathogenesis of this disease, creating a great challenge for the definition of efficient treatments for Alzheimer's disease (AD). Current therapeutic option for AD patients is the use of acetylcholinesterase (AChE) inhibitors, which gives only a symptomatic relief. However, recent studies show a long-lasting effect in a certain percentage of patients. In fact, there is accumulating evidence that an AChE has secondary non-cholinergic functions including the processing and deposition of beta-amyloid (Abeta). AChE could play a role in the Abeta metabolism and during an early step in the development of the senile plaque, as revealed by the finding that AChE accelerates Abeta deposition. Considering the non-classical AChE functions, their relationships with AD hallmarks, and the putative role of peripheral anionic site in all these functions, the dual binding site AChE inhibitors may acquire importance for AD treatment. On the other hand, the interference of AChE inhibitors with Abeta processing is not a general rule for this class of compounds with the involvement of other features such as chemical structure and/or genetic regulation. This review highlights the collection of several compounds with an outstanding profile against AChE-induced amyloid aggregation and potent AChE inhibitory activity, indicating the possibility of targeting Abeta through the inhibition of AChE and reveals the emergence of a new generation of AChE inhibitors aiming to be excellent candidate drugs for the future cure of Alzheimer's disease.

Integrity signals

Registry

Crossref · 10.2174/138161206778792985

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A new and rapid colorimetric determination of acetylcholinesterase activity
Ellman, G. L., Courtney, K. D., Andres, V., & Featherstone, R. M. (1961) · Biochemical Pharmacology · doi:10.1016/0006-2952(61)90145-9 · Cited by 27,221
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
The Cation−π Interaction
Jennifer, C., & Dougherty, D. A. (1997) · Chemical Reviews · doi:10.1021/cr9603744 · Cited by 3,518
Acetylcholinesterase — new roles for an old actor
Soreq, H., & Seidman, S. (2001) · Nature reviews. Neuroscience · doi:10.1038/35067589 · Cited by 1,437
Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207
Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the Enzyme
Inestrosa, N. C., Alvarez, A. R., Pérez, C. A., Moreno, R. D., Vicente, M., Linker, C., Casanueva, O. I., Soto, C. A., & Garrido, J. (1996) · Neuron · doi:10.1016/s0896-6273(00)80108-7 · Cited by 1,117
Release of Alzheimer Amyloid Precursor Derivatives Stimulated by Activation of Muscarinic Acetylcholine Receptors
Nitsch, R. M., Slack, B. E., Wurtman, R. J., & Growdon, J. H. (1992) · Science · doi:10.1126/science.1411529 · Cited by 898
beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies.
Bartolini, M., Bertucci, C., Cavrini, V., & Andrisano, V. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01514-9 · Cited by 523
Strategies for disease modification in Alzheimer's disease
Citron, M. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1495 · Cited by 430
Cholinesterases: New Roles in Brain Function and in Alzheimer's Disease
Giacobini, E. (2003) · Neurochemical Research · doi:10.1023/a:1022869222652 · Cited by 374

Show all 75 references

Sorted by citations

Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
Colovic, M. B., Krstic, D. Z., Lazarevic-Pasti, T. D., Bondzic, A. M., & Vasic, V. M. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311030006 · Cited by 2,611
Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Recent advances in the multitarget‐directed ligands approach for the treatment of Alzheimer's disease
Leon, R. M., García, A. G., & Marco, J. L. (2011) · Medicinal Research Reviews · doi:10.1002/med.20248 · Cited by 447
CHOLINESTERASES, A TARGET OF PHARMACOLOGY AND TOXICOLOGY
Pohanka, M. (2011) · Biomedical Papers · doi:10.5507/bp.2011.036 · Cited by 377
Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research
Hampel, H. J., Mesulam, M. M., Cuello, A. C., Khachaturian, A. S., Vergallo, A., Farlow, M. R., Snyder, P. J., Giacobini, E., & Khachaturian, Z. S. (2019) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2018.43 · Cited by 374
New Tacrine–4-Oxo-4H-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimer’s Disease, with Cholinergic, Antioxidant, and β-Amyloid-Reducing Properties
Fernández‐Bachiller, M. I., Pérez, C., Monjas, L., Rademann, J., & Rodrı́guez-Franco, M. I. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201460y · Cited by 271
Novel Tacrine−8-Hydroxyquinoline Hybrids as Multifunctional Agents for the Treatment of Alzheimer’s Disease, with Neuroprotective, Cholinergic, Antioxidant, and Copper-Complexing Properties
Fernández‐Bachiller, M. I., Pérez, C., González-Muñoz, G. C., Conde, S., López, M. G., Villarroya, M., Garcı́a, A. G., & Rodrı́guez-Franco, M. I. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100329q · Cited by 270
Multi-Target-Directed Drug Design Strategy: From a Dual Binding Site Acetylcholinesterase Inhibitor to a Trifunctional Compound against Alzheimer’s Disease
Bolognesi, M. L., Cavalli, A., Valgimigli, L., Bartolini, M., Rosini, M., Andrisano, V., Recanatini, M., & Melchiorre, C. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm701225u · Cited by 266
Synthesis, Biological Evaluation, and Molecular Modeling of Donepezil and N-[(5-(Benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine Hybrids as New Multipotent Cholinesterase/Monoamine Oxidase Inhibitors for the Treatment of Alzheimer’s Disease
Bolea, I., Juárez‐Jiménez, J., Rı́os, C. D. L., Chioua, M., Pouplana, R., Luque, F. J., Unzeta, M., Marco, J. L., & Samadi, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200853t · Cited by 220
Cholinesterase Inhibitors and Beyond
Pepeu, G., & Giovannini, M. (2009) · Current Alzheimer Research · doi:10.2174/156720509787602861 · Cited by 209
Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
Camps, P., Formosa, X., Galdeano, C., Gómez, T., Muñoz-Torrero, D., Scarpellini, M., Viayna, E., Badía, A., Clos, M. V., Camins, A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8001313 · Cited by 194
Oxidative Stress in Alzheimer’s Disease: Are We Connecting the Dots?
Rosini, M., Simoni, E., Milelli, A., Minarini, A., & Melchiorre, C. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400970m · Cited by 202
Pyrano[3,2-c]quinoline−6-Chlorotacrine Hybrids as a Novel Family of Acetylcholinesterase- and β-Amyloid-Directed Anti-Alzheimer Compounds
Camps, P., Formosa, X., Galdeano, C., Muñoz‐Torrero, D., Ramírez, L., Gómez, E., Isambert, N., Lavilla, R., Badı́a, A., Clos, M. V., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900859q · Cited by 174
Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015)
McHardy, S. F., Wang, H.-Y. L., McCowen, S. V., & Valdez, M. C. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1272571 · Cited by 167
Tacrine–Melatonin Hybrids as Multifunctional Agents for Alzheimer's Disease, with Cholinergic, Antioxidant, and Neuroprotective Properties
Fernández‐Bachiller, M. I., Pérez, C., Campillo, N. E., Paez, J. A., González-Muñoz, G. C., Usán, P., García‐Palomero, E., López, M. G., Villarroya, M., Garcı́a, A. G., et al. (2009) · ChemMedChem · doi:10.1002/cmdc.200800414 · Cited by 160
Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents
Viayna, E., Sola, I., Bartolini, M., Simone, A. D., Tapia‐Rojas, C., Serrano, F. G., Sabaté, R., Juárez‐Jiménez, J., Pérez, B., Luque, F. J., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401824w · Cited by 156
Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease
Wang, L., Esteban, G., Ojima, M., Bautista‐Aguilera, Ó. M., Inokuchi, T., Moraleda, I., Iriepa, I., Samadi, A., Youdim, M. B. H., Romero, A., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.078 · Cited by 143
Tacripyrines, the First Tacrine−Dihydropyridine Hybrids, as Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease
Marco, J. L., Leon, R. M., Rı́os, C. D. L., Samadi, A., Bartolini, M., Andrisano, V., Huertas, Ó., Barril, X., Luque, F. J., Rodrı́guez-Franco, M. I., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801292b · Cited by 136
Novel Tacrine–Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography
Zha, X., Lamba, D., Zhang, L., Lou, Y., Xu, C., Kang, D., Chen, L., Xu, Y., Zhang, L., Simone, A. D., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01119 · Cited by 135
Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease
Joubert, J., Foka, G. B., Repsold, B. P., Oliver, D. W., Kapp, E., & Malan, S. F. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.041 · Cited by 123
Boom in the development of non‐peptidic β‐secretase (BACE1) inhibitors for the treatment of Alzheimer's disease
Silvestri, R. (2008) · Medicinal Research Reviews · doi:10.1002/med.20132 · Cited by 118
Memoquin: A Multi-Target–Directed Ligand as an Innovative Therapeutic Opportunity for Alzheimer's Disease
Bolognesi, M. L., Cavalli, A., & Melchiorre, C. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.10.042 · Cited by 117
Synthesis of new donepezil analogues and investigation of their effects on cholinesterase enzymes
Sağlık, B. N., Ilgın, S., & Özkay, Y. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.10.042 · Cited by 117
Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer’s Disease Therapy
Arya, A., Chahal, R., Rao, R., Rahman, M. H., Kaushik, D., Akhtar, M. F., Saleem, A., Khalifa, S. M. A., El-Seedi, H. R., Kamel, M., et al. (2021) · Biomolecules · doi:10.3390/biom11030350 · Cited by 111
“Moreover, the conformational changes due to AChE-Aβ complex formation also enhanced the metabolism of Aβ and senile plaque generation [30].”
Background
A review of pharmacological and pharmacokinetic properties of Forsythiaside A
Gong, L., Wang, C., Zhou, H., Ma, C., Zhang, Y., Peng, C. Y., & Li, Y. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105690 · Cited by 110
Synergistic Effects of Curcumin and Piperine as Potent Acetylcholine and Amyloidogenic Inhibitors With Significant Neuroprotective Activity in SH-SY5Y Cells via Computational Molecular Modeling and in vitro Assay
Manap, A. S. A., Tan, A. C. W., Leong, W. H., Chia, A. Y. Y., Vijayabalan, S., Arya, A., Wong, E. H., Rizwan, F., Bindal, U., Koshy, S., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00206 · Cited by 113
Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors
Daoud, I., Melkemi, N., Salah, T., & Ghalem, S. (2018) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2018.03.021 · Cited by 110
Neuroprotective and Cholinergic Properties of Multifunctional Glutamic Acid Derivatives for the Treatment of Alzheimer’s Disease
Arce, M. P., Rodrı́guez-Franco, M. I., González-Muñoz, G. C., Pérez, C., López, B., Villarroya, M., López, M. G., Garcı́a, A. G., & Conde, S. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900628z · Cited by 109
Tacrine-6-Ferulic Acid, a Novel Multifunctional Dimer, Inhibits Amyloid-β-Mediated Alzheimer's Disease-Associated Pathogenesis In Vitro and In Vivo
Pi, R., Mao, X., Chao, X., Cheng, Z., Liu, M., Duan, X., Ye, M., Chen, X., Mei, Z., Liu, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031921 · Cited by 104
Donepezil-Based Central Acetylcholinesterase Inhibitors by Means of a “Bio-Oxidizable” Prodrug Strategy: Design, Synthesis, and in Vitro Biological Evaluation
Peauger, L., Azzouz, R., Gembus, V., Ţînţaş, M.-L., Santos, J. S. O., Bohn, P., Papamicaël, C. A., & Levacher, V. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00702 · Cited by 99
Design, synthesis and evaluation of novel tacrine–rhein hybrids as multifunctional agents for the treatment of Alzheimer's disease
Li, S., Jiang, N., Xie, S., Wang, K. D. G., Wang, X., & Kong, L. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob42010h · Cited by 96
Multi-target Design Strategies in the Context of Alzheimer’s Disease: Acetylcholinesterase Inhibition and NMDA Receptor Antagonism as the Driving Forces
Rosini, M., Simoni, E., Minarini, A., & Melchiorre, C. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1250-1 · Cited by 95
Pinus halepensis essential oil attenuates the toxic Alzheimer’s amyloid beta (1-42)-induced memory impairment and oxidative stress in the rat hippocampus
Postu, P. A., Sadiki, F. Z., Idrissi, M. E., Cioancă, O., Trifan, A., Hăncianu, M., & Hriţcu, L. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108673 · Cited by 92
A multifunctional therapeutic approach: Synthesis, biological evaluation, crystal structure and molecular docking of diversified 1H-pyrazolo[3,4-b]pyridine derivatives against Alzheimer's disease
Umar, T., Shalini, S., Raza, M. K., Gusain, S., Kumar, J., Seth, P., Tiwari, M., & Hoda, N. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.04.038 · Cited by 89
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
Cheong, S. L., Tiew, J. K., Fong, Y. H., Leong, H. W., Chan, Y. M., Chan, Z. L., & Kong, E. W. J. (2022) · Pharmaceuticals · doi:10.3390/ph15121560 · Cited by 94
Natural acetylcholinesterase inhibitors: A multi-targeted therapeutic potential in Alzheimer's disease
Kumar, G., K., P. G., Poornima, D. V., Shantaram, M., & Ranjita, G. (2024) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2024.100154 · Cited by 101
Synthesis and evaluation of dihydropyrimidinone-derived selenoesters as multi-targeted directed compounds against Alzheimer’s disease
Barbosa, F. A. R., Canto, R. F. S., Saba, S., Rafique, J., & Braga, A. L. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.09.031 · Cited by 87
Oxidative Stress, Mitochondrial Abnormalities and Proteins Deposition: Multitarget Approaches in Alzheimer's Disease
Giulia, N., Sestito, S., Digiacomo, M., & Rapposelli, S. (2017) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026617666170607114232 · Cited by 86
Cystamine-tacrine dimer: A new multi-target-directed ligand as potential therapeutic agent for Alzheimer’s disease treatment
Minarini, A., Milelli, A., Tumiatti, V., Rosini, M., Simoni, E., Bolognesi, M. L., Andrisano, V., Bartolini, M., Motori, E., Angeloni, C., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.10.007 · Cited by 85
Discovery of Novel Tacrine–Pyrimidone Hybrids as Potent Dual AChE/GSK-3 Inhibitors for the Treatment of Alzheimer’s Disease
Yao, H., Uras, G., Zhang, P., Xu, S., Yin, Y., Liu, J., Qin, S., Li, X., Allen, S., Bai, R., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00160 · Cited by 83
RETRACTED ARTICLE: Neuroprotective effect of ipriflavone against scopolamine-induced memory impairment in rats
Hafez, H. S., Ghareeb, D. A., Saleh, S. R., Abady, M. M., Demellawy, M. E., Hussien, H. M., & Abdel-Monem, N. M. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4690-x · Cited by 83
Retracted
Synthesis, Inhibitory Activity of Cholinesterases, and Neuroprotective Profile of Novel 1,8-Naphthyridine Derivatives
Rı́os, C. D. L., Egea, J., Marco, J. L., Leon, R. M., Samadi, A., Iriepa, I., Moraleda, I., Galvez‐Ruano, E., Garcı́a, A. G., López, M. G., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901902w · Cited by 79
Multitarget Strategies in Alzheimer’S Disease: Benefits and Challenges on the Road to Therapeutics
Rosini, M., Simoni, E., Caporaso, R., & Minarini, A. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0003 · Cited by 79
Design, synthesis and biological evaluation of novel coumarin- N -benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease
Lan, J., Ding, Y., Liu, Y., Kang, P., Hou, J., Zhang, X., Xie, S., & Zhang, T. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.055 · Cited by 76
BDNF-, IGF-1- and GDNF-Secreting Human Neural Progenitor Cells Rescue Amyloid β-Induced Toxicity in Cultured Rat Septal Neurons
Kitiyanant, N., Kitiyanant, Y., Svendsen, C. N., & Thangnipon, W. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0592-1 · Cited by 76
Dual Inhibitors of β-Amyloid Aggregation and Acetylcholinesterase as Multi-Target Anti-Alzheimer Drug Candidates
Viayna, E., Sabaté, R., & Muñoz‐Torrero, D. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113139990139 · Cited by 77
Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer's disease
Chen, Z., Digiacomo, M., Tu, Y., Gu, Q., Wang, S., Yang, X., Chu, J., Chen, Q., Han, Y., Chen, J., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.052 · Cited by 75
Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: Synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine
Samadi, A., Rı́os, C. D. L., Bolea, I., Chioua, M., Iriepa, I., Moraleda, I., Bartolini, M., Andrisano, V., Galvez‐Ruano, E., Valderas, C., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.03.022 · Cited by 71
Synthesis and evaluation of novel 1,2,3-triazole-based acetylcholinesterase inhibitors with neuroprotective activity
Li, J., Zhang, J., Rodrigues, M. C., Ding, D., Longo, J. P. F., Azevedo, R. B., Muehlmann, L. A., & Jiang, C. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.07.017 · Cited by 71
Synthesis, biological assessment and molecular modeling of new multipotent MAO and cholinesterase inhibitors as potential drugs for the treatment of Alzheimer’s disease
Samadi, A., Chioua, M., Bolea, I., Rı́os, C. D. L., Iriepa, I., Moraleda, I., Bastida, Á., Esteban, G., Unzeta, M., Galvez‐Ruano, E., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.05.048 · Cited by 70
Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease
Maalej, E., Chabchoub, F., Oset‐Gasque, M. J., Esquivias-Pérez, M., González, M. P., Monjas, L., Pérez, C., Rı́os, C. D. L., Rodrı́guez-Franco, M. I., Iriepa, I., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.06.038 · Cited by 69
N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a New Cholinesterase and Monoamine Oxidase Dual Inhibitor
Bautista‐Aguilera, Ó. M., Samadi, A., Chioua, M., Nikolic, K. M., Filipić, S., Agbaba, D., Soriano, E., de Andrés, L., Rodrı́guez-Franco, M. I., Alcaro, S., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501501a · Cited by 67
Protective effects of low molecular weight chondroitin sulfate on amyloid beta (Aβ)-induced damage in vitro and in vivo
Zhang, Q., Li, J., Liu, C., Song, C., Li, P., Yin, F., Xiao, Y., Li, J., Jiang, W., Zong, A., et al. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.002 · Cited by 66
Alzheimer's disease and related neurodegenerative disorders: implication and counteracting of melatonin
Pohanka, M. (2011) · Journal of Applied Biomedicine · doi:10.2478/v10136-011-0003-6 · Cited by 64
Novel Triazole-Quinoline Derivatives as Selective Dual Binding Site Acetylcholinesterase Inhibitors
Mantoani, S. P., Chierrito, T. P. C., Vilela, A. F. L., Cardoso, C. L., Martı́nez, A., & Carvalho, I. (2016) · Molecules · doi:10.3390/molecules21020193 · Cited by 65
Synthesis and pharmacological assessment of diversely substituted pyrazolo[3,4-b]quinoline, and benzo[b]pyrazolo[4,3-g][1,8]naphthyridine derivatives
SILVA, D. N. N. D., Chioua, M., Samadi, A., Carreiras, M. C., Jimeno, M. L., Mendes, E., Rı́os, C. D. L., Romero, A., Villarroya, M., López, M. G., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.05.068 · Cited by 61
Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer’s disease
Zou, D., Liu, R., Lv, Y., Guo, J., Zhang, C., & Xie, Y. (2023) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2023.2270781 · Cited by 60
Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer's Disease
Ahmed, T., Zahid, S., Mahboob, A., & Farhat, S. M. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160325121145 · Cited by 60
Drug repurposing for Alzheimer’s disease: in silico and in vitro investigation of FDA-approved drugs as acetylcholinesterase inhibitors
Kumar, N., Gahlawat, A., Kumar, R. N., Singh, Y. P., Modi, G. P., & Garg, P. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1844054 · Cited by 55
Toxicological and pharmacological evaluation, antioxidant, ADMET and molecular modeling of selected racemic chromenotacrines {11-amino-12-aryl-8,9,10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ols} for the potential prevention and treatment of Alzheimer's disease
Oset‐Gasque, M. J., González, M. P., Pérez‐Peña, J., García-Font, N., Romero, A., del Pino, J., Ramos, E., Hadjipavlou‐Litina, D., Soriano, E., Chioua, M., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.12.021 · Cited by 55
Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles
Samadi, A., Marco, J. L., Soriano, E., Álvarez-Pérez, M., Chioua, M., Romero, A., González‐Lafuente, L., Gandı́a, L., Roda, J. M., López, M. G., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.06.095 · Cited by 55
Cholinesterase Inhibitor Therapy in Alzheimer’s Disease: The Limits and Tolerability of Irreversible CNS-Selective Acetylcholinesterase Inhibition in Primates
Moss, D. E., Perez, R. G., & Kobayashi, H. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160733 · Cited by 55
Phenserine
Klein, J. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.7.1087 · Cited by 56
Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity
Vafadarnejad, F., Mahdavi, M. R., Karimpour‐Razkenari, E., Edraki, N., Sameem, B., Khanavi, M., Saeedi, M., & Akbarzadeh, T. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.01.013 · Cited by 54
Multi-Target-Directed Ligands as an Effective Strategy for the Treatment of Alzheimer’s Disease
Kumar, R., Kumar, V., Kumar, B., Thakur, A., & Dwivedi, A. R. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210512005508 · Cited by 55
Novel oxoisoaporphine-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation
Tang, H., Zhao, H.-T., Zhong, S., Wang, Z., Chen, Z., & Liang, H. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.01.090 · Cited by 53
Synthesis and discovery of highly functionalized mono- and bis-spiro-pyrrolidines as potent cholinesterase enzyme inhibitors
Kia, Y., Osman, H., Kumar, R. S., Basiri, A., & Murugaiyah, V. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.02.019 · Cited by 53
Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors
Deb, P. K., Sharma, A., Piplani, P., & Akkinepally, R. R. (2012) · Molecular Diversity · doi:10.1007/s11030-012-9394-x · Cited by 51
Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's disease
García-Font, N., Hayour, H., Ali Belfaitah, A., Pedraz, J., Moraleda, I., Iriepa, I., Bouraiou, A., Chioua, M., Marco, J. L., & Oset‐Gasque, M. J. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.04.023 · Cited by 51
Synthesis and AChE Inhibitory Activity of Novel Thiazolylhydrazone Derivatives
Osmani̇ye, D., Sağlık, B. N., Çevik, U. A., Levent, S., Çavuşoğlu, B. K., Özkay, Y., Kaplancıklı, Z. A., & Turan, G. (2019) · Molecules · doi:10.3390/molecules24132392 · Cited by 51
Dual-Acting Cholinesterase–Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo
Scheiner, M., Dolles, D., Gunesch, S., Hoffmann, M., Nabissi, M., Marinelli, O., Naldi, M., Bartolini, M., Petralla, S., Poeta, E., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00623 · Cited by 49
Synthesis and biological assessment of diversely substituted furo[2,3-b]quinolin-4-amine and pyrrolo[2,3-b]quinolin-4-amine derivatives, as novel tacrine analogues
Martins, C., Carreiras, M. C., Leon, R. M., Rı́os, C. D. L., Bartolini, M., Andrisano, V., Iriepa, I., Moraleda, I., Galvez‐Ruano, E., García, M. E., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.09.038 · Cited by 49
Study of the interactions of forsythiaside and rutin with acetylcholinesterase (AChE)
Yan, X., Chen, T., Zhang, L., & Du, H. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.07.144 · Cited by 49
Spirulina maxima Extract Ameliorates Learning and Memory Impairments via Inhibiting GSK-3β Phosphorylation Induced by Intracerebroventricular Injection of Amyloid-β 1–42 in Mice
Koh, E.-J., Kim, K.-J., Song, J.-H., Choi, J., Lee, H., Kang, D.-H., Heo, H., & Lee, B.-Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112401 · Cited by 48
Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles
Samadi, A., Valderas, C., Rı́os, C. D. L., Bastida, Á., Chioua, M., González‐Lafuente, L., Colmena, I., Gandı́a, L., Romero, A., del Barrio, L., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.11.040 · Cited by 47
Benzophenone-based derivatives: A novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation
Belluti, F., Bartolini, M., Bottegoni, G., Bisi, A., Cavalli, A., Andrisano, V., & Rampa, A. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.02.019 · Cited by 46
A Facile Ionic Liquid Promoted Synthesis, Cholinesterase Inhibitory Activity and Molecular Modeling Study of Novel Highly Functionalized Spiropyrrolidines
Almansour, A. I., Kumar, R. S., Arumugam, N., Basiri, A., Kia, Y., Ali, M. A.-S., Farooq, M., & Murugaiyah, V. (2015) · Molecules · doi:10.3390/molecules20022296 · Cited by 46
Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Aβ accumulation and cell death: Involvement in hippocampal neuronal loss in Alzheimer's disease
Antequera, D., Bolós, M., Spuch, C., Pascual, C., Ferrer, I., Fernández‐Bachiller, M. I., Rodrı́guez-Franco, M. I., & Carro, E. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.009 · Cited by 46
Potent β-Amyloid Modulators
García‐Palomero, E., Muñoz, P., Usán, P., Garcia, P., Delgado, E., de Austria, C., Valenzuela, R., Rubio, L., Medina, M., & Martı́nez, A. (2008) · Neurodegenerative Diseases · doi:10.1159/000113688 · Cited by 45
Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer’s disease
Dam, D. V., Coen, K., & Deyn, P. P. D. (2007) · Psychopharmacology · doi:10.1007/s00213-007-1010-x · Cited by 44
Bis(7)‐tacrine Derivatives as Multitarget‐Directed Ligands: Focus on Anticholinesterase and Antiamyloid Activities
Bolognesi, M. L., Bartolini, M., Mancini, F., Chiriano, G., Ceccarini, L., Rosini, M., Milelli, A., Tumiatti, V., Andrisano, V., & Melchiorre, C. (2010) · ChemMedChem · doi:10.1002/cmdc.201000086 · Cited by 42
Discovery of novel isoflavone derivatives as AChE/BuChE dual-targeted inhibitors: synthesis, biological evaluation and molecular modelling
Feng, B., Li, X., Xia, J., & Wu, S. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2017.1347163 · Cited by 42
Novel donepezil-like N-benzylpyridinium salt derivatives as AChE inhibitors and their corresponding dihydropyridine “bio-oxidizable” prodrugs: Synthesis, biological evaluation and structure-activity relationship
Azzouz, R., Peauger, L., Gembus, V., Ţînţaş, M.-L., Santos, J. S. O., Papamicaël, C. A., & Levacher, V. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.12.084 · Cited by 42
Dual inhibition: a novel promising pharmacological approach for different disease conditions
Patyar, S., Prakash, A., & Medhi, B. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01236.x · Cited by 45
New Huprine Derivatives Functionalized at Position 9 as Highly Potent Acetylcholinesterase Inhibitors
Ronco, C., Foucault, R., Gillon, É., Bohn, P., Nachon, F., Jean, L., & Renard, P. (2011) · ChemMedChem · doi:10.1002/cmdc.201000523 · Cited by 41
Protective effects of Forsythoside A on amyloid beta-induced apoptosis in PC12 cells by downregulating acetylcholinesterase
Yan, X., Chen, T., Zhang, L., & Du, H. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.07.009 · Cited by 40
Potential acetylcholinesterase inhibitors: molecular docking, molecular dynamics, and in silico prediction
Kiametis, A. S., Silva, M. A., Romeiro, L. A. S., Martins, J. B. L., & Gargano, R. (2017) · Journal of Molecular Modeling · doi:10.1007/s00894-017-3228-9 · Cited by 40
Attenuation of Scopolamine-Induced Amnesia via Cholinergic Modulation in Mice by Synthetic Curcumin Analogs
Hussain, H., Ahmad, S., Shah, S. W. A., Ullah, A., Ali, N., Almehmadi, M. M., Ahmad, M., Khalil, A. A. K., Jamal, S. B., Ahmad, H., et al. (2022) · Molecules · doi:10.3390/molecules27082468 · Cited by 42
Huprine Derivatives as Sub‐Nanomolar Human Acetylcholinesterase Inhibitors: From Rational Design to Validation by X‐ray Crystallography
Ronco, C., Carletti, E., Colletier, J., Weik, M., Nachon, F., Jean, L., & Renard, P. (2011) · ChemMedChem · doi:10.1002/cmdc.201100438 · Cited by 39
Neuroprotective Potential of Synthetic Mono-Carbonyl Curcumin Analogs Assessed by Molecular Docking Studies
Hussain, H., Ahmad, S., Shah, S. W. A., Ghias, M., Ullah, A., Rahman, S. U., Kamal, Z., Khan, F. A., Khan, N. M., Muhammad, J., et al. (2021) · Molecules · doi:10.3390/molecules26237168 · Cited by 40
Derivatives and Analogues of Resveratrol: Recent Advances in Structural Modification
Li, Q., Li, Y., Deora, G. S., & Ruan, B. (2019) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557519666190128093840 · Cited by 36
Discovery of potent glycogen synthase kinase 3/cholinesterase inhibitors with neuroprotection as potential therapeutic agent for Alzheimer’s disease
Jiang, X., Wang, Y., Liu, C., Xing, C., Wang, Y., Lyu, W., Wang, S., Li, Q., Chen, T., Chen, Y., et al. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115940 · Cited by 38
Design, synthesis and evaluation of novel bivalent β-carboline derivatives as multifunctional agents for the treatment of Alzheimer's disease
Zhao, Y., Ye, F., Xu, J., Liao, Q., Chen, L., Zhang, W., Sun, H., Liu, W., Feng, F., & Qu, W. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.06.018 · Cited by 37
Synthesis, biological assessment and molecular modeling of 14-aryl-10,11,12,14-tetrahydro-9H-benzo[5,6]chromeno[2,3-b]quinolin-13-amines
Maalej, E., Chabchoub, F., Samadi, A., Rı́os, C. D. L., Perona, A., Morreale, A., & Marco, J. L. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.02.094 · Cited by 36
Recent Developments on Synthesis Strategies, SAR Studies and Biological Activities of β-Carboline Derivatives – An Update
Abinaya, R., Srinath, S., Soundarya, S., Sridhar, R., Balasubramanian, K. K., & Baskar, B. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.132750 · Cited by 36
Cholinesterase inhibitors: a patent review (2007 – 2011)
Rı́os, C. D. L. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.701619 · Cited by 35
Biological evaluation and molecular docking of novel 1,3,4-thiadiazole-resorcinol conjugates as multifunctional cholinesterases inhibitors
Skrzypek, A., Matysiak, J., Karpińska, M. M., Czarnecka, K., Kręcisz, P., Stary, D., Kukułowicz, J., Paw, B., Bajda, M., Szymański, P., et al. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104617 · Cited by 34
Azo-Stilbene and Pyridine–Amine Hybrid Multifunctional Molecules to Target Metal-Mediated Neurotoxicity and Amyloid-β Aggregation in Alzheimer’s Disease
Rana, M., Cho, H., Arya, H., Bhatt, T. K., Bhar, K., Bhatt, S., Mirica, L. M., & Sharma, A. K. (2022) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.2c00502 · Cited by 33
Assessment of antioxidant, anticholinesterase and antiamyloidogenic effect of Terminalia chebula, Terminalia arjuna and its bioactive constituent 7-Methyl gallic acid – An in vitro and in silico studies
Pugazhendhi, A., Shafreen, R. B., Devi, K. P., & Suganthy, N. (2018) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2018.02.081 · Cited by 33
Design, Synthesis and Biological Evaluation of Xanthone Derivatives for Possible Treatment of Alzheimer's Disease Based on Multi‐Target Strategy
Yang, A., Yu, Q., Ju, H., Song, L., Kou, X., & Shen, R. (2020) · Chemistry & Biodiversity · doi:10.1002/cbdv.202000442 · Cited by 33

Authors: Castro, A., & Martinez, A.
ORCID: Castro, Ana
Venue: Current Pharmaceutical Design
Publisher: Bentham Science Publishers Ltd.
Published: 2006-11-01
Volume: 12
Issue: 33
Pages: 4377-4387
ISSN: 1381-6128 (ISSN-L)
DOI: 10.2174/138161206778792985
OpenAlex: W1976042714
Cited by: 207
References: 75
Citations by year: 2026: 7 · 2025: 5 · 2024: 12 · 2023: 7 · 2022: 13 · 2021: 13 · 2020: 12 · 2019: 10 · 2018: 7 · 2017: 16 · 2016: 16 · 2015: 11 · 2014: 9 · 2013: 8 · 2012: 15
FWCI: 5.22
Type: journal article
Language: en
Open access: closed
Locations: Current Pharmaceutical Design (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Enzyme function and inhibition
Keywords: Alzheimer's disease, amyloid-beta, acetylcholinesterase inhibitors, amyloid fibril formation, peripheral anionic site, dual binding site inhibitors, amyloid plaques, amyloid deposition
MeSH terms: Alzheimer Disease, Cholinesterase Inhibitors, Humans, Amyloid beta-Peptides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Targeting Beta-Amyloid Pathogenesis Through Acetylcholinesterase Inhibitors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks